^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Merkel Cell Carcinoma |
| Drug: | Imlygic (talimogene laherparepvec) (GM-CSF agonist) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/10/2023
Excerpt:
Merkel Cell Carcinoma...Useful in Certain Circumstances:...Oncolytic viral therapy (talimogene laherparepvec [T-VEC]) (category 2B)
